19740
tert-Butyl carbazate
purum, ≥98.0% (GC)
Synonym(s):
tert-Butoxycarbonyl hydrazide, Boc-hydrazide
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
(CH3)3COCONHNH2
CAS Number:
Molecular Weight:
132.16
EC Number:
212-795-3
UNSPSC Code:
12352108
PubChem Substance ID:
Beilstein/REAXYS Number:
1756967
MDL number:
InChI key
DKACXUFSLUYRFU-UHFFFAOYSA-N
InChI
1S/C5H12N2O2/c1-5(2,3)9-4(8)7-6/h6H2,1-3H3,(H,7,8)
SMILES string
O=C(NN)OC(C)(C)C
grade
purum
assay
≥98.0% (GC)
bp
63-65 °C/0.1 mmHg (lit.)
mp
38-42 °C, 39-42 °C (lit.)
application(s)
peptide synthesis
Other Notes
Starting material for preparing BOC-azide, a reagent to introduce the BOC amino protection; E. Wünsch in Houben-Weyl, Vol. 15/1, Synthese von grossen Peptiden, p. 112.; Reagent for the synthesis of sulfonic and carboxylic hydrazides
This product has been replaced by B91005-ALDRICH | tert-Butyl carbazate 98%
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
M.S. Gordon et al.
Synthesis, 244-244 (1980)
Martina Bruna Violatto et al.
ACS nano, 13(4), 4410-4423 (2019-03-19)
Steroids are the standard therapy for autoimmune hepatitis (AIH) but the long-lasting administration is hampered by severe side effects. Methods to improve the tropism of the drug toward the liver are therefore required. Among them, conjugation to nanoparticles represents one
Tomáš Etrych et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 58, 1-12 (2014-03-19)
In this study, we describe the synthesis, physico-chemical characterisation and results of the in vitro and in vivo evaluation of the biological behaviour of N-(2-hydroxypropyl)methacrylamide-based (HPMA) copolymer conjugates bearing doxorubicin (DOX) partly bound via a pH-sensitive hydrazone and partly via
Jeong-A Yang et al.
Acta biomaterialia, 12, 174-182 (2014-10-12)
Liver fibrosis is a chronic liver disease caused by viral infection and/or metabolic, genetic and cholestatic disorders. The inhibition of hepatic stellate cell (HSC) activation and the selective apoptosis of activated HSCs can be a good strategy to treat liver
Joshua O Sestak et al.
The AAPS journal, 16(6), 1185-1193 (2014-09-07)
Presentation of antigen with immune stimulating "signal" has been a cornerstone of vaccine design for decades. Here, the antigen plus immune "signal" of vaccines is modified to produce antigen-specific immunotherapies (antigen-SITs) that can potentially reprogram the immune response toward tolerance
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service